Michael J. Olek

4.8k total citations · 1 hit paper
38 papers, 3.2k citations indexed

About

Michael J. Olek is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Michael J. Olek has authored 38 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pathology and Forensic Medicine, 10 papers in Immunology and 6 papers in Oncology. Recurrent topics in Michael J. Olek's work include Multiple Sclerosis Research Studies (25 papers), Polyomavirus and related diseases (4 papers) and Immunotherapy and Immune Responses (4 papers). Michael J. Olek is often cited by papers focused on Multiple Sclerosis Research Studies (25 papers), Polyomavirus and related diseases (4 papers) and Immunotherapy and Immune Responses (4 papers). Michael J. Olek collaborates with scholars based in United States, Canada and Germany. Michael J. Olek's co-authors include Miguel A. Hernán, Alberto Ascherio, Kassandra L. Munger, S. M. Zhang, Walter C. Willett, Éilis J. O’Reilly, Shumin M. Zhang, Susan S. Jick, Donna Spiegelman and Susan E. Hankinson and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Michael J. Olek

37 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vitamin D intake and incidence of multiple sclerosis

2004 808 citations Kassandra L. Munger, Miguel A. Hernán et al. profile →

Peers

Michael J. Olek

PFM

IMMUN

RHEUM

EPIDE

ONCOL

Lahiru Handunnetthi United Kingdom

Rune Midgard Norway

Johann Sellner Germany

Marianna Cortese United States

Ute‐Christiane Meier United Kingdom

Terry A. McNearney United States

Jacques M. Lemire United States

Pauline M. Dowd United Kingdom

Thomas R. Cupps United States

Ilana Katz Sand United States

Lahiru Handunnetthi United Kingdom

Michael J. Olek

1.4k ×0.6

PFM

661 ×0.7

IMMUN

223 ×0.5

RHEUM

272 ×0.6

EPIDE

270 ×0.6

ONCOL

Citations per year, relative to Michael J. Olek Michael J. Olek (= 1×) peers Lahiru Handunnetthi

Countries citing papers authored by Michael J. Olek

Since Specialization

Citations

This map shows the geographic impact of Michael J. Olek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Olek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Olek more than expected).

Fields of papers citing papers by Michael J. Olek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Olek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Olek. The network helps show where Michael J. Olek may publish in the future.

Co-authorship network of co-authors of Michael J. Olek

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Olek. A scholar is included among the top collaborators of Michael J. Olek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Olek. Michael J. Olek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Olek, Michael J., et al.. (2021). Emerging Neuralink Brain Machine Interface Technology: An Oversight Proposal to Address the Ethical, Legal, and Social Implications. Journal of Legal Medicine. 41(sup1). 40–41.

Alonso, Álvaro, Susan S. Jick, Michael J. Olek, & Miguel A. Hernán. (2007). Incidence of multiple sclerosis in the United Kingdom. Journal of Neurology. 254(12). 1736–1741. 72 indexed citations

Olek, Michael J., et al.. (2006). Diagnosis and Management of Multiple Sclerosis: Case Studies. Neurologic Clinics. 24(2). 199–214. 4 indexed citations

Olek, Michael J.. (2005). Multiple Sclerosis. Humana Press eBooks. 3 indexed citations

Alonso, Álvaro, Susan S. Jick, Michael J. Olek, et al.. (2005). Recent Use of Oral Contraceptives and the Risk of Multiple Sclerosis. Archives of Neurology. 62(9). 1362–1362. 99 indexed citations

Zhang, Yiping, Lutz G.W. Hilgenberg, Raymond A. Sobel, et al.. (2005). Axon Reactive B Cells Clonally Expanded in the Cerebrospinal Fluid of Patients with Multiple Sclerosis. Journal of Clinical Immunology. 25(3). 254–264. 48 indexed citations

Hernán, Miguel A., Susan S. Jick, Giancarlo Logroscino, et al.. (2005). Cigarette smoking and the progression of multiple sclerosis. Brain. 128(6). 1461–1465. 215 indexed citations

Zhang, Yiping, Lutz G.W. Hilgenberg, Wallace W. Tourtellotte, et al.. (2005). Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions. Journal of Neuroimmunology. 167(1-2). 120–130. 43 indexed citations

Smith, Duane R., Bianca Weinstock‐Guttman, Jeffrey A. Cohen, et al.. (2005). A randomized blinded trial of combination therapy with cyclophosphamide in patients with active multiple sclerosis on interferon beta. Multiple Sclerosis Journal. 11(5). 573–582. 58 indexed citations

10.

Qin, Yufen, Pierre Duquette, Yiping Zhang, et al.. (2003). Intrathecal B-Cell Clonal Expansion, an Early Sign of Humoral Immunity, in the Cerebrospinal Fluid of Patients with Clinically Isolated Syndrome Suggestive of Multiple Sclerosis. Laboratory Investigation. 83(7). 1081–1088. 86 indexed citations

11.

Munger, Kassandra L., Rosanna Ŵ. Peeling, Miguel A. Hernán, et al.. (2003). Infection with Chlamydia pneumoniae and Risk of Multiple Sclerosis. Epidemiology. 14(2). 141–147. 49 indexed citations

12.

Ascherio, Alberto, Kassandra L. Munger, Donna Spiegelman, et al.. (2001). Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis. JAMA. 286(24). 3083–3083. 1 indexed citations

13.

Ascherio, Alberto, Shumin M. Zhang, Miguel A. Hernán, et al.. (2001). Hepatitis B Vaccination and the Risk of Multiple Sclerosis. New England Journal of Medicine. 344(5). 327–332. 273 indexed citations

14.

Hernán, Miguel A., Shumin M. Zhang, Loren Lipworth, Michael J. Olek, & Alberto Ascherio. (2001). Multiple Sclerosis and Age at Infection with Common Viruses. Epidemiology. 12(3). 301–306. 107 indexed citations

15.

Zhang, Shumin M., Walter C. Willett, Miguel A. Hernán, Michael J. Olek, & Alberto Ascherio. (2000). Dietary Fat in Relation to Risk of Multiple Sclerosis among Two Large Cohorts of Women. American Journal of Epidemiology. 152(11). 1056–1064. 99 indexed citations

16.

Olek, Michael J., et al.. (1999). Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis. Journal of Osteopathic Medicine. 99(3). 165–165. 17 indexed citations

17.

Olek, Michael J.. (1999). Multiple sclerosis--Part 2. Treatment strategies. Journal of Osteopathic Medicine. 99(12). 611–611. 1 indexed citations

18.

Olek, Michael J.. (1999). Multiple sclerosis--Part I. Overview pathophysiology, diagnostic evaluation, and clinical parameters. Journal of Osteopathic Medicine. 99(11). 574–574. 9 indexed citations

19.

Hohol, Marika, Michael J. Olek, E. John Orav, et al.. (1999). Treatment of progressive multiple sclerosis with pulse cyclophosphamidel methylprednisolone: Response to therapy is linked to the duration of progressive disease. Multiple Sclerosis Journal. 5(6). 403–409. 55 indexed citations

20.

Balashov, Konstantin, Michael J. Olek, Derek R. Smith, Samia J. Khoury, & Howard L. Weiner. (1998). Seasonal variation of interferon‐γ production in progressive multiple sclerosis. Annals of Neurology. 44(5). 824–828. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact